Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes.
暂无分享,去创建一个
Jin Cui | Hongyuan Song | Jiacan Su | Liehu Cao | W. Weng | Hongyuan Song | Jiacan Su | Liehu Cao | Yan Hu | Xiaoqun Li | Xiao Chen | Xiaoqun Li | Zichang Zhao | Jin Qian | Yao Wang | Weizong Weng | Xiao Chen | Yan Hu | J. Cui | Yao Wang | Zichang Zhao | Jin Qian
[1] R. Baron,et al. Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate. , 2017, Cell metabolism.
[2] Jinxiang Han,et al. Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression , 2016, FEBS letters.
[3] Yuliang Zhao,et al. Exosomes as extrapulmonary signaling conveyors for nanoparticle-induced systemic immune activation. , 2012, Small.
[4] T. Mizoguchi,et al. The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts , 2016, Journal of Bone and Mineral Metabolism.
[5] Wei Wei,et al. Interferon‐β‐induced miR‐155 inhibits osteoclast differentiation by targeting SOCS1 and MITF , 2012, FEBS letters.
[6] F. Sánchez‐Madrid,et al. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins , 2016, Nature Communications.
[7] I. Reid. Short-term and long-term effects of osteoporosis therapies , 2015, Nature Reviews Endocrinology.
[8] A. Mangoni,et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis , 2016, Nature Communications.
[9] F. Dignat-George,et al. Extracellular Vesicles in Angiogenesis , 2017, Circulation research.
[10] R. Gregory,et al. MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.
[11] Jian Song,et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.
[12] J. Mann,et al. Serotonin reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local antiresorptive effect , 2016, Nature Medicine.
[13] Jianlin Shi,et al. Exosome Biochemistry and Advanced Nanotechnology for Next‐Generation Theranostic Platforms , 2018, Advanced materials.
[14] C James Kirkpatrick,et al. Improving vascularization of engineered bone through the generation of pro-angiogenic effects in co-culture systems. , 2015, Advanced drug delivery reviews.
[15] R. Agami,et al. miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate , 2010, Proceedings of the National Academy of Sciences.
[16] Eric C. Lai,et al. Adult-specific functions of animal microRNAs , 2013, Nature Reviews Genetics.
[17] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[18] R. Adams,et al. Blood vessel formation and function in bone , 2016, Development.
[19] Y. Liu,et al. Transplantation of SHED Prevents Bone Loss in the Early Phase of Ovariectomy-induced Osteoporosis , 2014, Journal of dental research.
[20] S. Mathivanan,et al. ExoCarta: A compendium of exosomal proteins and RNA , 2009, Proteomics.
[21] Xu Cao,et al. Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice , 2018, Theranostics.
[22] Laurence Zitvogel,et al. Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.
[23] Guodong Yang,et al. In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9. , 2018, Nano letters.
[24] A. Teti,et al. Bone cells and the mechanisms of bone remodelling. , 2012, Frontiers in bioscience.
[25] Carla Oliveira,et al. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. , 2016, ACS nano.
[26] C. Coch,et al. Exosomes as nucleic acid nanocarriers. , 2013, Advanced drug delivery reviews.
[27] Sha Li,et al. Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function , 2015, Genom. Proteom. Bioinform..
[28] N. LeBrasseur,et al. Targeting cellular senescence prevents age-related bone loss in mice , 2017, Nature Medicine.
[29] I. Rigoutsos,et al. Gene-expression forum: Decoy for microRNAs , 2010, Nature.
[30] J. Gallagher,et al. Prevention and treatment of postmenopausal osteoporosis , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[31] Liang Wang,et al. Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity , 2016, Cell Discovery.
[32] R. Adams,et al. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.
[33] L. Duong,et al. PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis , 2014, Nature Medicine.
[34] K. Drescher,et al. Exosomal miRNAs: Biological Properties and Therapeutic Potential , 2012, Front. Gene..
[35] W. Tan,et al. Molecular Recognition-Based DNA Nanoassemblies on the Surfaces of Nanosized Exosomes. , 2017, Journal of the American Chemical Society.
[36] R. Adams,et al. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone , 2014, Nature.
[37] S. Grundmann,et al. MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization , 2015, Circulation.
[38] Masaki Noda,et al. Osteoclast‐specific Dicer gene deficiency suppresses osteoclastic bone resorption , 2009, Journal of cellular biochemistry.
[39] Clotilde Théry,et al. Biogenesis and secretion of exosomes. , 2014, Current opinion in cell biology.
[40] E. M. Lewiecki,et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis , 2014, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.
[41] D. Hose,et al. Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma. , 2017, Blood.
[42] W. B. van den Berg,et al. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. , 2011, Arthritis and rheumatism.
[43] Xiaojuan He,et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation , 2016, Nature Communications.
[44] S. Teitelbaum,et al. Bone resorption by osteoclasts. , 2000, Science.
[45] Xin Tian,et al. Nanoparticle-induced exosomes target antigen-presenting cells to initiate Th1-type immune activation. , 2012, Small.
[46] R. Adams,et al. Osteoclast progenitors promote bone vascularization and osteogenesis , 2014, Nature Medicine.